Quick Answer
Stem cell therapy and clinical trials are not the same thing. Stem cell therapy describes an intervention that uses stem cells or cell-based products, while a clinical trial is a structured research study designed to evaluate an intervention and answer specific questions about its safety, effectiveness, or other outcomes. A stem cell therapy may be investigated in a clinical trial, but being described as a “clinical trial” does not mean the treatment has been proven effective or approved for routine use.
Understanding this distinction is important when researching regenerative medicine, particularly when a treatment is described as “experimental,” “investigational,” or “clinically studied.”
What Is Stem Cell Therapy?
Stem cell therapy is a broad term for medical interventions that use stem cells or other cell-based products with the intention of influencing or repairing biological processes.
Stem cells have the ability to self-renew and, depending on their type, can develop into or support specialised cell populations. Researchers are studying different types of stem cells for different diseases, injuries and biological processes.
However, “stem cell therapy” does not describe one single treatment.
Different interventions can vary in:
- the type of cells used
- where the cells come from
- how the cells are collected
- how they are processed
- whether they are expanded or otherwise modified
- the dose administered
- how they are delivered
- the condition being investigated
- how outcomes are measured
These differences matter because evidence for one cell-based intervention cannot automatically be applied to another.
The International Society for Stem Cell Research (ISSCR) notes that many stem cell treatments remain experimental and that researchers are still determining which cells may be appropriate for particular conditions, how they should be delivered and what their long-term safety may be.
This is why it is more useful to ask “Which stem cell intervention, for which condition, and what evidence supports it?” than simply asking whether “stem cell therapy” works.
What Is a Clinical Trial?
A clinical trial is a structured research study involving people that is designed to answer specific questions about an intervention.
ClinicalTrials.gov defines an interventional study, or clinical trial, as a study in which participants are assigned to one or more interventions according to a protocol so researchers can evaluate their effects on health-related outcomes.
A clinical trial can investigate:
- a new treatment
- a new use of an existing treatment
- a different dose or treatment schedule
- a different method of administration
- a medical procedure
- a biological product
- or another intervention
Trials may use different study designs. Depending on the research question, participants may be assigned to different treatment groups, receive a comparison treatment or placebo, or receive the intervention without a control group.
The purpose is not simply to give participants a treatment. The purpose is to generate evidence.
A well-designed clinical trial therefore has a defined protocol, eligibility criteria, outcome measures and procedures for collecting and analysing data.
Stem Cell Therapy vs Clinical Trials: The Key Difference
The simplest way to understand the distinction is:
Stem cell therapy describes an intervention; a clinical trial describes a research process used to evaluate an intervention.
A stem cell intervention can therefore be the subject of a clinical trial.
The two terms are related, but they are not interchangeable.
| Stem Cell Therapy | Clinical Trial | |
| What is it? | A broad term for a cell-based intervention | A structured research study |
| Primary purpose | May be intended to provide a therapeutic effect | To answer defined research questions |
| What is evaluated? | Depends on the specific intervention | Safety, effectiveness, and/or other predefined outcomes |
| Is it automatically proven? | No | No |
| Is it automatically approved? | No | No |
| Can it be experimental? | Yes | Clinical trials commonly evaluate investigational interventions |
| Does it have a protocol? | Depends on the setting | Yes, a clinical trial follows a defined study protocol |
| Does participation prove the treatment works? | No | No |
| Can it involve a control group? | Not necessarily | Often, depending on study design |
The most important point is that a clinical trial is a method of evaluating a treatment, not a certification that the treatment works.
Does Being in a Clinical Trial Mean a Stem Cell Treatment Works?
No. Participation in a clinical trial does not mean that the treatment has been proven effective.
A clinical trial exists because researchers still need to answer questions about the intervention.
Depending on the stage and design of the study, researchers may be investigating:
- whether the intervention is safe
- what side effects occur
- what dose is appropriate
- whether the intervention produces a measurable biological effect
- whether patients experience a meaningful clinical benefit
- how the intervention compares with another treatment
- how long any observed effects last
Early-stage studies may involve relatively small numbers of participants and focus heavily on safety and feasibility.
Later-stage trials may involve larger populations and more rigorous comparisons.
The ISSCR explains that clinical trials are designed to determine whether a potential treatment reliably produces its intended medical benefit and is safe. It also stresses that the treatment being tested remains unproven during the research process.
Therefore:
Clinical trial ≠ proven treatment
Clinical trial ≠ approved treatment
Clinical trial = research designed to generate evidence
Also Read: Stem Cell Therapy Explained: What Does the Current Research Actually Tell Us?
Are All Stem Cell Treatments Experimental?
No. But many stem cell interventions remain experimental or investigational, depending on the condition, product, intended use and regulatory jurisdiction.
Some stem-cell-based treatments have established medical uses. Others are still being studied.
The important distinction is between:
Established treatment
An intervention has gone through an appropriate evidence and regulatory process for a particular indication and is accepted for clinical use in that jurisdiction.
Experimental or investigational intervention
An intervention is still being evaluated, or is being used in a way that has not been established as safe and effective for the particular condition.
The ISSCR describes an experimental intervention as something new, untested or different from usual medical treatment for which safety and effectiveness for the particular disease or condition have not yet been established.
This means that the phrase “stem cell therapy” alone does not tell a patient whether a particular intervention is established or experimental.
The specific product, indication, protocol, and regulatory status need to be considered.
How Do Stem Cell Treatments Become Established Medical Therapies?
Developing a new cell-based treatment generally involves several stages of research.
1. Basic and Laboratory Research
Researchers first study cells, tissues, and biological mechanisms to understand how an intervention might work.
2. Preclinical Research
Potential interventions may then be studied in laboratory models and, where appropriate, animal models.
These studies can provide information about biological activity, potential mechanisms and safety considerations.
3. Early Clinical Research
If there is sufficient scientific rationale and appropriate oversight, researchers may begin studying an intervention in people.
Early clinical research often focuses on safety, tolerability, feasibility, and how the intervention behaves in the body.
4. Later Clinical Trials
As evidence develops, larger or more rigorous trials may be conducted to evaluate effectiveness and compare outcomes.
Depending on the research question, trials may be randomized, controlled, or blinded.
5. Regulatory Review
Where applicable, regulatory authorities review the available evidence before a treatment can be approved for a particular use.
The ISSCR describes this progression from basic research through preclinical work and clinical trials toward regulatory review as part of clinical translation.
Importantly, not every intervention that enters clinical research will ultimately become an approved treatment.
Research can show that an approach is ineffective, has unacceptable risks, or requires further development.
What Does a Clinical Trial Actually Tell Us?
A clinical trial can provide valuable evidence, but the amount and quality of evidence depend on its design and results.
When reading about a stem cell clinical trial, it is useful to ask:
What phase is the study?
The phase can provide context about the stage of development, although terminology and requirements can vary depending on the jurisdiction and type of intervention.
How many people participated?
A small study may provide useful early information but may not be sufficient to establish effectiveness across a broader population.
Was there a control group?
A comparison group can help researchers determine whether observed changes are likely to be associated with the intervention.
Was the study randomized?
Randomization can reduce certain forms of bias by assigning participants to study groups according to a predefined process.
Were participants or researchers blinded?
Blinding can reduce the influence of expectations when appropriate for the intervention and study design.
What outcomes were measured?
Researchers should define meaningful outcomes in advance and analyse them systematically.
Were the results statistically and clinically meaningful?
A statistically detectable difference does not automatically mean that the difference is large enough to be meaningful to patients.
Were the findings reproduced?
A result from one study becomes more informative when supported by independent research.
The ISSCR notes that well-designed clinical trials use predefined endpoints to objectively assess whether an investigational treatment provides benefit and to generate evidence about safety and efficacy.
Does ClinicalTrials.gov Approval Mean a Treatment Is Approved?
No. Being listed on ClinicalTrials.gov does not mean that a treatment has been approved or proven effective.
ClinicalTrials.gov is a database that provides information about clinical research studies. It includes both interventional studies and observational studies.
The website itself states that the US government does not review or approve the safety and science of every study listed in the database. Responsibility for the accuracy and regulatory compliance of a study record rests with the study sponsor or investigator.
This is an important distinction for patients researching stem cell treatments online.
A listing can show that a study exists, but it does not by itself demonstrate:
- that the intervention works
- that it is safe
- that the intervention is approved
- that the study has produced positive results
- that the intervention can legally be marketed as a treatment
The FDA makes a similar point, stating that inclusion of a product in ClinicalTrials.gov does not itself mean that the product is legally marketed or FDA-approved.
What Does Regulatory Approval Mean?
Regulatory approval is different from clinical-trial participation.
Approval generally means that the relevant regulatory authority has reviewed evidence according to its legal and scientific requirements and determined that a product or intervention can be used for a specified indication under defined conditions.
Importantly, approval is usually indication-specific.
A product being approved for one condition does not automatically mean it is approved for another.
The FDA states that regenerative medicine products intended to treat disease generally require FDA approval for marketing in the United States. Its consumer guidance also states that regenerative medicine therapies have not been approved to treat autism and lists a range of other conditions for which such therapies have not been approved.
Regulatory frameworks differ internationally, so patients considering treatment outside their home country should check the status of the specific intervention, indication, and jurisdiction rather than relying on general claims about “stem cell approval.”
Can an Experimental Treatment Be Offered Outside a Clinical Trial?
This is an important question, because experimental and clinical trial are related but not identical terms.
The ISSCR states that an experimental procedure does not automatically mean it is part of a formal clinical trial. It also recommends that experimental stem cell interventions be subject to appropriate oversight and that patients receive clear information about their unproven nature and risks.
Regulatory requirements vary by country, so the legal status of an intervention must be assessed within the relevant jurisdiction.
Patients should therefore ask:
Is this treatment part of a registered and appropriately overseen clinical trial, or is it being offered outside a clinical research study?
That question can reveal an important difference between participating in research and receiving an intervention as a private treatment.
What Should Patients Check Before Considering Stem Cell Therapy?
If you are researching a stem cell intervention, don’t rely solely on phrases such as:
- “clinically proven”
- “clinically tested”
- “research-backed”
- “FDA registered”
- “clinical trial available”
- “approved stem cells”
Instead, ask for specific evidence.
1. What exact cells are being used?
Find out the cell type, source, and how the cells are prepared.
2. What condition and indication have been studied?
Evidence for one condition does not automatically apply to another.
3. What clinical studies support the intervention?
Ask for published research and study identifiers where appropriate.
4. What were the study results?
Look beyond the existence of a study and examine what it actually found.
5. Was there a control group?
This can be important when interpreting whether observed changes were attributable to the intervention.
6. What risks are known?
Ask about both short-term risks and what is known about long-term safety.
7. What is the regulatory status?
Confirm whether the specific intervention is approved, investigational, or otherwise regulated for the intended use.
8. Is the treatment part of a clinical trial?
If so, ask about the trial sponsor, study protocol, eligibility requirements, and oversight.
9. How will outcomes be monitored?
A responsible treatment pathway should explain what will be assessed before, during, and after an intervention.
10. What happens if the treatment does not produce the expected result?
Understanding alternatives and follow-up is part of informed decision-making.
The ISSCR recommends that patients carefully investigate the science, expected outcomes, risks, and oversight surrounding stem cell interventions before making decisions about treatment.
Why the Distinction Matters
The difference between stem cell therapy and a clinical trial is more than a terminology issue.
It affects how patients interpret evidence.
Consider these statements:
“This stem cell treatment is being studied in a clinical trial.”
This tells you that researchers are evaluating the intervention.
It does not tell you that the treatment has been proven effective.
Similarly:
“The treatment has been clinically tested.”
This may sound reassuring, but you still need to know:
- what was tested
- in whom
- how many participants were involved
- what the study design was
- what outcomes were measured
- whether there was a control
- what the results showed
- whether the findings were independently reproduced
The strongest patient decisions are based on the quality and relevance of evidence, not simply the presence of scientific terminology.
Stem Cell Therapy vs Clinical Trials: A Simple Way to Remember
A useful way to remember the difference is:
Stem cell therapy = the intervention.
Clinical trial = the research study used to evaluate an intervention.
Experimental = the intervention has not yet been established as safe and effective for the particular use.
Regulatory approval = the relevant authority has authorised the specific product or intervention for a defined use under its regulatory framework.
These concepts can overlap, but they should not be treated as synonyms.
What Does This Mean for Patients?
If you are considering a stem cell intervention, the most important question is not simply:
“Is this a stem cell treatment?”
A better set of questions is:
What exactly is being offered?
What evidence supports this specific intervention for my condition?
Is it experimental or approved for this use?
Is it being evaluated through a clinical trial?
What are the known risks and uncertainties?
What regulatory framework applies where the treatment is being provided?
This approach helps separate genuine clinical evidence from broad claims about regenerative medicine.
Stem cell research continues to develop across many areas of medicine. Some interventions have established uses, while many others remain under investigation. Understanding where a particular treatment sits within that evidence and regulatory pathway is essential before making healthcare decisions.
Considering Regenerative Medicine?
If you are researching stem cell therapy or another regenerative medicine approach, understanding the evidence is an important first step.
A specialist assessment can help you discuss your medical circumstances, existing care, available research, and the questions that may be relevant to your individual situation.
Speak With NeoStem Turkey About Your Questions
Frequently Asked Questions
Is stem cell therapy the same as a clinical trial?
No. Stem cell therapy describes a cell-based intervention, while a clinical trial is a structured research study designed to evaluate an intervention. A stem cell therapy may be investigated in a clinical trial, but the two terms are not interchangeable. A clinical trial does not automatically mean that the treatment being studied has been proven effective or approved.
Does a clinical trial mean a stem cell treatment works?
No. A clinical trial is conducted because researchers are evaluating questions about an intervention. Depending on its stage and design, a trial may assess safety, tolerability, effectiveness or other outcomes. Results must be analysed before conclusions can be drawn about whether a treatment provides meaningful clinical benefit.
Are all stem cell treatments experimental?
No. Some stem-cell-based treatments have established medical uses, while many other interventions remain experimental or investigational. Whether a particular treatment is established depends on the specific cells or product, condition, intended use, evidence, and regulatory jurisdiction. The term “stem cell therapy” by itself does not establish the treatment’s approval status.
Does being listed on ClinicalTrials.gov mean a treatment is approved?
No. ClinicalTrials.gov is a database of clinical research studies and does not itself approve the safety or effectiveness of every study listed. The FDA also states that inclusion of a product or study in ClinicalTrials.gov does not mean the product is legally marketed or FDA-approved.
What is the difference between experimental and approved treatment?
An experimental intervention has not yet been established as safe and effective for the particular use, whereas an approved treatment has undergone the applicable evidence and regulatory process for a defined indication. Approval is generally specific to the product and intended use rather than applying to every possible use of a therapy.
Can a stem cell treatment be offered outside a clinical trial?
An experimental procedure is not automatically a clinical trial. Whether an investigational intervention can legally or ethically be provided outside a formal trial depends on the applicable regulatory framework, the intervention, and the circumstances. Patients should ask whether a proposed treatment is part of a registered and appropriately overseen clinical study and should understand its evidence and risks.
What should I look for when evaluating a stem cell treatment?
Look for evidence relating to the specific intervention and condition, including published clinical research, study design, participant numbers, outcomes, safety information and regulatory status. It is also important to establish whether the intervention is part of a clinical trial and who is responsible for clinical oversight. The ISSCR recommends that patients investigate the science, expected outcomes, risks, and oversight before considering an experimental stem cell intervention.
Why are clinical trials important for stem cell therapies?
Clinical trials allow researchers to systematically evaluate potential treatments in people. Depending on the design, they can provide information about safety, effectiveness, appropriate dosing, treatment delivery, and other outcomes. Well-designed trials can also use controls, randomization, or blinding to reduce bias and produce more reliable evidence.